Literature DB >> 27726319

Medication Assisted Treatment for Opioid Use Disorders Reporting Requirements. Final rule.zzm321990

.   

Abstract

This final rule outlines annual reporting requirements for practitioners who are authorized to treat up to 275 patients with covered medications in an office-based setting. This final rule will require practitioners to provide information on their annual caseload of patients by month, the number of patients provided behavioral health services and referred to behavioral health services, and the features of the practitioner's diversion control plan. These reporting requirements will help the Department of Health and Human Services (HHS) ensure compliance with the requirements of the final rule, "Medication Assisted Treatment for Opioid Use Disorders," published in the Federal Register on July 8, 2016.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27726319

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  3 in total

1.  Effects of Global Payment and Accountable Care on Medication Treatment for Alcohol and Opioid Use Disorders.

Authors:  Julie M Donohue; Colleen L Barry; Elizabeth A Stuart; Shelly F Greenfield; Zirui Song; Michael E Chernew; Haiden A Huskamp
Journal:  J Addict Med       Date:  2018 Jan/Feb       Impact factor: 3.702

2.  Growth and Distribution of Buprenorphine-Waivered Providers in the United States, 2007-2017.

Authors:  Ryan K McBain; Andrew Dick; Mark Sorbero; Bradley D Stein
Journal:  Ann Intern Med       Date:  2020-01-07       Impact factor: 25.391

3.  Program development and implementation outcomes of a statewide addiction consultation service: Maryland Addiction Consultation Service (MACS).

Authors:  Sarah Sweeney; Kelly Coble; Elizabeth Connors; Kathleen Rebbert-Franklin; Christopher Welsh; Eric Weintraub
Journal:  Subst Abus       Date:  2020-08-19       Impact factor: 3.716

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.